Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -52.46% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 20.09%. Over the past 30 days, the price of RVNC has leaped by -18.70%. And in the last five days, it has fallen by -28.44%.
Revance Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $9.74 on 01/02/24, while the lowest price for the same duration was marked at $2.30 on 06/26/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of RVNC Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Revance Therapeutics Inc’s current trading price is -57.12% away from its 52-week high, while its distance from the 52-week low is 81.70%. The stock’s price range during this time has been between $2.30 and $9.74. The trading volume for the Healthcare sector company’s shares reached about 3.89 million for the day, which was lower than the average daily volume of 4.79 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Revance Therapeutics Inc (RVNC) has experienced a quarterly decline of -36.49% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 438.38M and boasts a workforce of 597 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.93, with a change in price of +1.42. Similarly, Revance Therapeutics Inc recorded 3,849,936 in trading volume during the last 100 days, posting a change of +53.38%.
RVNC Stock Stochastic Average
Today, Revance Therapeutics Inc’s raw stochastic average for the past 50 days stands at 22.29%, indicating a decline from the raw stochastic average of the last 20 days, which was 26.37%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 12.69% and 32.70% respectively.
